スポンサーリンク
Department Of Hematology And Oncology Wakayama Medical University | 論文
- Aggressive CD5-positive B-cell lymphoma after remission of CD5-negative follicular lymphoma with distinct immunoglobulin heavy chain rearrangement and translocation
- Amplification and overexpression of the PRAD1/Cyclin D1 gene in a multiple myeloma cell line
- Aggressive CD5-positive diffuse large B cell lymphoma showing c-myc rearrangements developed in a patient with autoimmune hemolytic anemia
- Cyclin-dependent kinase 1 inhibitor RO-3306 enhances p53-mediated Bax activation and mitochondrial apoptosis in AML
- New Insights into Molecular Pathogenesis of Bone Marrow Failure in Paroxysmal Nocturnal Hemoglobinuria
- Paroxysmal Nocturnal Hemoglobinuria
- A Novel Type of Factor XI Deficiency Showing Compound Genetic Abnormalities: A Nonsense Mutation and an Impaired Transcription
- Serum amino acid disturbance in multiple myeloma with hyperammonemia
- Hyperdiploid myeloma cell as an indicator of poor prognosis and drug refractoriness
- Bone marrow large B cell lymphoma bearing cyclin D3 expression : clinical, morphologic, immunophenotypic, and genotypic analyses of seven patients
- Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab
- Successful treatment with liposomal doxorubicin for widespread Kaposi's sarcoma and human herpesvirus-8 related severe hemophagocytic syndrome in a patient with acquired immunodeficiency syndrome
- Establishment of CD5 and CD10 double-positive mature B-cell line, WILL1, showing complex 8q24 translocation involving 14q32 and 6q27
- Molecular Cloning of Translocation Breakpoint from der(8)t(3 ; 8)(q27 ; q24) Defines Juxtaposition of Downstream of C-MYC and Upstream of BCL6
- Down-regulation of Cyclin D3 by Small-interfering RNA Induces Cell Cycle Arrest and Apoptosis through the Dissociation of p27^ in a t(6 ; 14) (p21 ; q32) Positive Myeloma Cell Line
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
- Rapid Vanishing of Tumors by Withdrawal of Methotrexate in Epstein-Barr Virus-Related B cell Lymphoproliferative Disorder